The dosage typically starts at 0.25 mg (milligrams) once weekly
Setchell KD, Brown NM, Summer S, et al
As the patient titrates up in dose for either medication, the risk of side effects may increase
Prescribers screen for contraindications (e.g., certain endocrine tumor syndromes) and review your medical history for past issues, such as pancreatitis, when evaluating whether GLP-1 medication is appropriate
Patients using oral contraceptives should use a non-oral or backup contraceptive method for 4 weeks after tirzepatide initiation and after each dose increase
2.2 Study protocol In total, 130 patients with T2D attending our Clinic were screened for eligibility from December 01, 2021, to May 31, 2022